Impedimed's Sozo digital health platform garners breakthrough device designation for renal failure Aug. 31, 2021 By Catherine Longworth No Comments The FDA has designated Impedimed Ltd.’s Sozo digital health platform a breakthrough device for renal failure, paving the way for the first FDA approved device to measure fluid volume in the dialysis setting.Read More
First patient enrolled in trial on sirolimus drug-eluting balloon for erectile dysfunction Aug. 19, 2021 No Comments
Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS Aug. 11, 2021 No Comments
Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346 Aug. 10, 2021 No Comments
Phase I data with ANG-3070 pave way for phase II study in primary proteinuric kidney diseases Aug. 3, 2021 No Comments